To uncover meaningful biological insights from your targeted NGS data, you may be faced with several challenges, from choosing an appropriate library preparation method that covers specific targets of interest to connecting disparate informatics tools for sequence analysis and variant interpretation. These issues can be particularly critical when using custom NGS panel designs.

QIAGEN has developed an integrated workflow approach to address these NGS challenges.  In this live two-part webinar series, we will describe the latest QIAseq DNA Panel kits, which include:
• QIAseq Targeted DNA Panels: Generate uniform NGS libraries for low-frequency variant detection using Unique Molecular Indices (UMIs), and improve coverage of GC-rich regions using QIAseq Enrichment Technology
• CLC Genomics Workbench: Use pre-built sequence analysis workflows that can run in a push-button mode for all off-the-shelf QIAseq DNA panels, and that are easily configured for use with your custom QIAseq panel designs
• QIAGEN Clinical Insight-Interpret for QIAseq: Perform comprehensive variant interpretation with software that provides an easy-to-understand report for each variant detected in your sample, powered by the QIAGEN Knowledge Base, the industry’s most complete and up-to-date repository of curated scientific information

Used together in one kit, these best-in-class components allow you to design, execute and interpret NGS results in a single integrated workflow with the confidence that comes from the quality and support for which QIAGEN is known.  By attending both webinars, you will learn how to readily execute these integrated workflows–whether using your own custom-designed QIAseq DNA panels, or pre-built catalog panels. You will also gain an understanding and appreciation of the true value that comes from using all NGS components from a single supplier, who provides support for every aspect of the NGS workflow.
About the speaker
Raed Samara, Ph.D., Senior Global Product Manager
Raed Samara, PhD is a Global Product Manager for NGS technologies at QIAGEN, with a focus on pre-analytics and targeted enrichment. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.
Date of recording:Monday, November 4, 2019
Duration:60 minutes
Next Generation Sequencing
Cancer Research
Liquid Biopsy
Molecular Biology Research
Informatics & Data